Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, Changyoun, Ho, Dong-Hwan, Suk, Ji-Eun, You, Sungyong, Michael, Sarah, Kang, Junghee, Joong Lee, Sung, Masliah, Eliezer +3 more·2013·Nature Communications

DOI 10.1038/ncomms2534

Cited by (863)

Items 501–600 of 863

Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes
Jintang Wang, Zheng Chen, Jeremy D Walston, Peisong Gao, Maolong Gao, Sean Xiao Leng · 2019 · Molecular Neurobiology
Emerging contributions of formyl peptide receptors to neurodegenerative diseases
Lukas Busch, Stefan Vieten, Susan Brödel, Kristina Endres, Bernd Bufe · 2021 · Biological Chemistry
Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
Valdinocci, Dario, Grant, Gary D., Dickson, Tracey C., Pountney, Dean L. · 2018 · Molecular and Cellular Neuroscience
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
Fiona C. Weiss, Laura P. Hughes, YuHong Fu, Cédric Bardy, Glenda Margaret Halliday, Nicolas L. Dzamko · 2024 · Translational Neurodegeneration
Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies
Ahmed M Abdelaziz · 2025 · International Immunopharmacology
Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma Alicia Martínez-Dávila, Cecilia Bañuelos, María Eugenia Gutiérrez-Castillo, Víctor Manuel Blanco-Álvarez, María del Carmen Cárdenas‐Aguayo, José Luna‐Muñoz, Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas · 2021 · International Journal of Molecular Sciences
Recent Advances in Microglia Modelling to Address Translational Outcomes in Neurodegenerative Diseases
Carla Cuní‐López, Romal Stewart, Hazel Quek, Anthony Robert White · 2022 · Cells
Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease
Yazead Buhidma, Carl Hobbs, Marzia Malcangio, Susan Duty · 2023 · npj Parkinson s Disease
Circadian regulation of microglia function: Potential targets for treatment of Parkinson’s Disease
Liang Kou, Xiaosa Chi, Yadi Sun, Sijia Yin, Jiawei Wu, Wenkai Zou, Yiming Wang, Zongjie Jin, Jinsha Huang, Nian Xiong et al. · 2024 · Ageing Research Reviews
Innate immune memory: The evolving role of macrophages in therapy
Payal Damani‐Yokota, Kamal Mohan Khanna · 2025 · eLife
γδ T Cells Participating in Nervous Systems: A Story of Jekyll and Hyde
Yunxuan Li, Yixi Zhang, Xun Zeng · 2021 · Frontiers in Immunology
What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson’s Disease?
Amaryllis E. Hill, Richard Wade‐Martins, Philip W. J. Burnet · 2021 · Frontiers in Neuroscience
Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice
Shinya Okuda, Norihito Uemura, Masanori Sawamura, Tomoyuki Taguchi, Masashi Ikuno, Maiko T. Uemura, Hodaka Yamakado, Ryōsuke Takahashi · 2021 · Neurotherapeutics
A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology
Jessica Chedid, Adahir Labrador‐Garrido, Siying Zhong, Jianqun Gao, Ye Zhao, Gayathri Perera, Woojin Scott Kim, Glenda Margaret Halliday, Nicolas L. Dzamko · 2022 · Journal of Biological Chemistry
α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications
Amanda Li, Cyrus T. Rastegar, Xiaobo Mao · 2022 · Biomolecules
Nuclear localization of alpha-synuclein affects the cognitive and motor behavior of mice by inducing DNA damage and abnormal cell cycle of hippocampal neurons
Yue Pan, Qinglan Zong, Guoxiang Li, Zhengcun Wu, Tingfu Du, Zhangqiong Huang, Ying Zhang, Kaili Ma · 2022 · Frontiers in Molecular Neuroscience
Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
Nada Lawand, Nayef E. Saadé, Omar M. A. El‐Agnaf, Bared Safieh‐Garabedian · 2015 · Expert Opinion on Therapeutic Targets
Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Caterina Maria Gambino, Bruna Lo Sasso, Giulia Bivona, Luisa Agnello, Marcello Ciaccio · 2019 · Current Pharmaceutical Design
TLR2 antagonism attenuates the hippocampal neuronal damage in a murine model of sleep apnea via inhibiting neuroinflammation and oxidative stress
Yan Deng, Kui Liu, Yueying Pan, Jie Ren, Jin Shang, Lei Chen, Huiguo Liu · 2020 · Sleep And Breathing
Resistance of naturally secreted α‐synuclein to proteolysis
Methodios Ximerakis, Georgios Pampalakis, Theodoros I. Roumeliotis, Vasia Samantha Sykioti, Spiros D. Garbis, Leonidas Stefanis, Georgia Sotiropoulou, Kostas Vekrellis · 2014 · The FASEB Journal
Inhibition of Nigral Microglial Activation Reduces Age-Related Loss of Dopaminergic Neurons and Motor Deficits
Tzu-Feng Wang, Shih-Ying Wu, Bo‐Syong Pan, Sheng‐Feng Tsai, Yu‐Min Kuo · 2022 · Cells
α‐Synuclein Oligomers: A Study in Diversity
Femke van Diggelen, Armand W.J.W. Tepper, Mihaela M. Apetri, Daniel E. Otzen · 2016 · Israel Journal of Chemistry
Down‐regulation of natural resistance‐associated macrophage protein‐1 (Nramp1) is associated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)/1‐methyl‐4‐phenylpyridinium (MPP+)‐induced α‐synuclein accumulation and neurotoxicity
Kuang‐Chong Wu, Horng‐Huei Liou, Chun-Yao Lee, Chun‐Jung Lin · 2018 · Neuropathology and Applied Neurobiology
An interplay between immune response and neurodegenerative disease progression: An assessment using Drosophila as a model
Jyoti Dhankhar, Namita Agrawal, Anju Shrivastava · 2020 · Journal of Neuroimmunology
Transcriptome-wide analysis reveals core sets of transcriptional regulators of sensome and inflammation genes in retinal microglia
Madhu Sudhana Saddala, Yang Xu, Shibo Tang, Huang Hu · 2021 · Genomics
Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
Kelly A. Mills, Yong Du, Jennifer Marie Coughlin, Catherine A. Foss, Andrew G. Horti, Katelyn R. Jenkins, Yana Skorobogatova, Ergi Spiro, Chelsie Motley, Robert F. Dannals et al. · 2025 · Journal of Clinical Investigation
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Yiping Su, Zhanguo Su · 2025 · European journal of medical research
Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
Maria Argyrofthalmidou, Athanasios D. Spathis, Matina Maniati, Amalia Poula, Maria A. Katsianou, Evangelos Sotiriou, Maria Manousaki, Céline Perier, Ioanna Papapanagiotou, Zeta Papadopoulou‐Daifoti et al. · 2021 · Human Molecular Genetics
Spreading of alpha-synuclein between different cell types
Wolfgang Philipp Ruf, João L. Meirelles, Karin M. Danzer · 2022 · Behavioural Brain Research
PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
Peng Wang, Darrell E. Anderson, Yihong Ye · 2023 · Cell & Bioscience
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, Aaushi Pareek, Vivek Kumar Jain, Sonia Sonia, Zeba Farooqui, Ranjeet Kaur, Gurjit Singh · 2024 · Biomolecules
Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson’s disease
Xiangbo Zhang, Haiyang Yu, Juan Feng · 2024 · Frontiers in Aging Neuroscience
NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson’s disease
Asma Khan, Robert Johnson, Carrie Wittmer, Michelle Maile, Keith J. Tatsukawa, Julian L. Wong, Martin B. Gill, Emily M. Stocking, Srinivasa Reddy Natala, Amy Paulino et al. · 2021 · Brain
Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
María Dolores Cayero Otero, Ana M. Espinosa‐Oliva, Antonio J. Herrera, Irene García-Domínguez, Mercedes Fernández Arévalo, Lucía Martín‐Banderas, Rocío M. de Pablos · 2018 · Current Pharmaceutical Design
Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
Shraddha Patel, Chandrabhan Prajapati, Sachchida Nand, Santosh Kumar Singh · 2026 · 3 Biotech
Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s disease
Adamantios Mamais, Alice Kaganovich, Kirsten Harvey · 2022 · Neurobiology of Disease
Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model
Pietro La Vitola, Luisa Artioli, Milica Cerovic, Cristian Poletto, Letizia Dacomo, Susanna Leva, Claudia Balducci, Gianluigi Forloni · 2022 · Parkinsonism & Related Disorders
Involvement of Abnormal p-α-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson’s Disease: an Animal Model Study
Wenwen Jiang, Yue Cheng, Ye Wang, Jing Wu, Zhe Rong, Li Sun, Yan Zhou, Kezhong Zhang · 2023 · Molecular Neurobiology
Phosphorylated α-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson’s disease autonomic dysfunction
Yangxia Li, Qing Tong, Ye Wang, Yue Cheng, Yao Geng, Tian Tian, Yongsheng Yuan, Yi Fan, Ming Lu, Kezhong Zhang · 2024 · Cell Death Discovery
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson’s disease
Emi Furusawa-Nishii, Bataa Solongo, Rai Kou, Soichiro Yoshikawa, A. Chiba, A. Okuzumi, Shin-ichi Ueno, Y. Hoshino, Yoko Imamichi-Tatano, Haruka Kimura et al. · 2025 · Journal of Neuroinflammation
In vivo quantification of glial activation in minipigs overexpressing human α‐synuclein
Thea Pinholt Lillethorup, Andreas Nørgaard Glud, Natalie Landeck, Aage Kristian Olsen Alstrup, Steen Jakobsen, Kim Vang, Doris J. Doudet, David James Brooks, Deniz Kirik, Rainer Hinz et al. · 2018 · Synapse
Extracellular Alpha-Synuclein Promotes a Neuroinhibitory Secretory Phenotype in Astrocytes
Bruno Di Marco Vieira, Rowan A. W. Radford, Junna Hayashi, Emma D. Eaton, Ben Greenaway, Mark Jambas, Eugen Bogdan Petcu, Roger S. Chung, Dean L. Pountney · 2020 · Life
Prion-like propagation of α-synuclein in the gut-brain axis
Ying Chen, Qian-Hang Shao, Yu‐He Yuan, Nai‐Hong Chen · 2018 · Brain Research Bulletin
Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes
Chia, Sook-Yoong, Li, Mengwei, Li, Zhihong, Tu, Haitao, Lee, Jolene Wei Ling, Qiu, Lifeng, Ling, Jingjing, Reynolds, Richard, Albani, Salvatore, Tan, Eng-King et al. · 2025 · Genome Medicine
α-Synuclein in traumatic and vascular diseases of the central nervous system
Hong Zeng, Nan Liu, Xiao-Xie Liu, Yanyan Yang, Mouwang Zhou · 2020 · Aging
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex
Maria Francesca Palmas, Michela Etzi, Augusta Pisanu, Chiara Camoglio, Claudia Sagheddu, Michele Santoni, Maria Francesca Manchinu, Mauro Pala, Giuliana Fusco, Alfonso De Simone et al. · 2022 · Cells
Loss of cannabinoid receptor 2 promotes α-Synuclein-induced microglial synaptic pruning in nucleus accumbens by modulating the pCREB-c-Fos signaling pathway and complement system
Linjuan Feng, Hsuan Lo, Hanlin You, Wei Wu, Xiaojuan Cheng, Jiawei Xin, Zu‐Cheng Ye, Xiaochun Chen, Xiaodong Pan · 2022 · Experimental Neurology
Emerging trends in IRAK-4 kinase research
Himanshu Kumar Yadav, Raj Kumar Shirumalla · 2023 · Molecular Biology Reports
Inflammation and heterogeneity in synucleinopathies
Antoine Freuchet, Anaëlle Pinçon, Alessandro Sette, Cecilia S. Lindestam Arlehamn · 2024 · Frontiers in Immunology
TLR4 and TLR2 activation is differentially associated with age during Parkinson’s disease
Hermínio Maurício da Rocha Sobrinho, Delson José da Silva, Larissa Fonseca Gomides, Miriam Leandro Dorta, Milton Adriano Pelli de Oliveira, Fátima Ribeiro‐Dias · 2017 · Immunological Investigations
C. elegans Models to Study the Propagation of Prions and Prion-Like Proteins
Carl Alexander Sandhof, Simon Oliver Hoppe, Jessica Tittelmeier, Carmen I. Nussbaum-Krammer · 2020 · Biomolecules
Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson’s disease
Marie-Amandine Bonte, Fatima El Idrissi, Bernard Gressier, David Devos, Karim Bélarbi · 2021 · International Immunopharmacology
A functional role for alpha-synuclein in neuroimmune responses
Dustin L. Heiden, Brendan Monogue, Muhammad Ali, John David Beckham · 2023 · Journal of Neuroimmunology
Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
Peng Fei Guo, Ruidan Wang, Tenghong Lian, Du-yu Ding, Yanan Zhang, Weijiao Zhang, Dan-ning Li, Lixia Li, Jinghui Li, Huiying Guan et al. · 2020 · Frontiers in Aging Neuroscience
Aplp1 and the Aplp1-Lag3 Complex facilitates transmission of pathologic α-synuclein
Xiaobo Mao, Hao Gu, Donghoon Kim, Yasuyoshi Kimura, Ning Wang, Enquan Xu, Haibo Wang, Chan Chen, Shengnan Zhang, Chunyu Jia et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Käufer, Franziska Richter, Wouter Peelaerts · 2024 · Journal of Parkinson s Disease
The Multifaceted Role of LRRK2 in Parkinson’s Disease
Dong Hwan Ho, Sun Jung Han, Ilhong Son · 2025 · Brain Sciences
Non-canonical autophagy in aging and age-related diseases
Anita V. Kumar, Joslyn Mills · 2023 · Frontiers in Cell and Developmental Biology
Naïve Huntington’s disease microglia mount a normal response to inflammatory stimuli but display a partially impaired development of innate immune tolerance that can be counteracted by ganglioside GM1
Noam Steinberg, Danny Galleguillos, Asifa K. Zaidi, Melanie Horkey, Simonetta Sipione · 2023 · Journal of Neuroinflammation
A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates
Hiroo Yamaguchi, Yuji Nishimura, Dai Matsuse, Hiroaki Sekiya, Katsuhisa Masaki, Tatsunori Tanaka, Toru Saiga, Masaya Harada, Yuu‐ichi Kira, Dennis W. Dickson et al. · 2024 · Brain Behavior and Immunity
Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease
Shaoping Zhong, Yangye Lian, Binbin Zhou, Ruiqing Ren, Lewei Duan, Yuyin Pan, Yuchen Gong, Xiaoling Wu, Dengfeng Cheng, Pu-Ming Zhang et al. · 2024 · Acta Neuropathologica
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
Haoran Xiang · 2025 · Frontiers in Neuroscience
α -Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
Jingjing Cheng, Qingqing Lu, Song Li, Margaret Su-chun Ho · 2018 · ASN NEURO
Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy
Jin Young Shin, Phil Hyu Lee · 2020 · Stem Cell Research
Il-10 signaling reduces survival in mouse models of synucleinopathy
Samuel G. Cockey, Karen N. McFarland, Emily J. Koller, Mieu Brooks, Elsa Gonzalez De La Cruz, Pedro E. Cruz, Carolina Ceballos‐Diaz, Awilda M. Rosario, Yona Levites, David Borchelt et al. · 2021 · npj Parkinson s Disease
T-cell based immunotherapies for Parkinson’s disease
Rodrigo Pacheco · 2021 · Exploration of Neuroprotective Therapy
GBA1 and The Immune System: A Potential Role in Parkinson’s Disease?
Zaid A.M. Al‐Azzawi, Saman Arfaie, Ziv Gan‐Or · 2022 · Journal of Parkinson s Disease
Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells
Frank M. Bearoff, Dhruva D. Dhavale, Paul T. Kotzbauer, Sandhya Kortagere · 2022 · Molecular Immunology
The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease
Yan Shen, Xingfang Guo, Chao Han, Fang Jung Wan, Kai Ma, Shiyi Guo, Luxi Wang, Yun Fei Xia, Ling Liu, Zhicheng Lin et al. · 2017 · Cellular and Molecular Life Sciences
Peripheral–central immune interactions in Parkinson’s disease: insights into innate and adaptive immunity
Jarika Jahan Tumpa, Qurat Ul Ain Hayder, Nowshin Sharmily Maisa, Md. Nazmul Islam · 2025 · Frontiers in Molecular Neuroscience
Conformation-specific Antibodies Targeting Aggregated Forms of α-synuclein Block the Propagation of Synucleinopathy
Min-Sun Choi, Tae-Kyung Kim, Jin-Hyung Ahn, Jun Sung Lee, Byung Chul Jung, Sungwon An, Dongin Kim, Min Jae Lee, Inhee Mook‐Jung, Sang Hoon Lee et al. · 2022 · Experimental Neurobiology
Activation of the MAC1-ERK1/2-NOX2 Pathway Is Required for LPS-Induced Sustaining Reactive Microgliosis, Chronic Neuroinflammation and Neurodegeneration
Shih‐Heng Chen, Shuangyu Han, Chih-Fen Hu, Ran Zhou, Yun Gao, Dezhen Tu, Hui‐Ming Gao, Jing Feng, Yubao Wang, Ru‐Band Lu et al. · 2022 · Antioxidants
Antibodies and α-synuclein: What to target against Parkinson's Disease?
Daniel E. Otzen · 2023 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
Yongtao He, Jiayin Zhao, Hongtian Dong, Xiaoshuang Zhang, Yufei Duan, Yuanyuan Ma, Mei Yu, Jian Fei, Fang Ping Huang · 2023 · Life Sciences
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Jinsong Xue, Keju Tao, Weijia Wang, Xiaofei Wang · 2024 · International Journal of Molecular Sciences
The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer’s Disease, and mild cognitive impairment
Yueyi Yu, Huixin Shen, Qi Qin, Jing Wang, Yuting Nie, Lulu Wen, Yi Tang, Miao Qu · 2025 · Neuroscience
Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
Gabriella Margherita Mazzotta, Nadia Ceccato, Carmela Conte · 2023 · Cells
MultiTEP platform–based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency
Hayk Davtyan, Karen Zagorski, Irina Petrushina, Konstantin Kazarian, Natalie R.S. Goldberg, Janet Petrosyan, Mathew M. Blurton-Jones, Eliezer Masliah, David H. Cribbs, Michael G. Agadjanyan et al. · 2017 · Neurobiology of Aging
Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le · 2025 · Translational Neurodegeneration
Therapeutic Mechanisms of Exercise in Parkinson’s Disease
Alice C. Wilson, Dean L. Pountney, Tien Kheng Khoo · 2025 · International Journal of Molecular Sciences
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Yeseong Choi, Won‐Suk Chung · 2025 · Molecular Neurodegeneration
Alpha-Synuclein Inclusion Formation in Human Oligodendrocytes
Ye-Seul Yoon, Woo Jung Ahn, Diadem Ricarte, Darlene Mae Ortiz, Chan Young Shin, Seung‐Jae Lee, He-Jin Lee · 2020 · Biomolecules & Therapeutics
The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates
Carlo Scialò, Giuseppe Legname · 2020 · Progress in molecular biology and translational science
NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
Agata Habas, Srinivasa Reddy Natala, Jon K. Bowden-Verhoek, Emily M. Stocking, Diana L. Price, Wolfgang Wrasidlo, Douglas W. Bonhaus, Martin B. Gill · 2022 · International Journal of Inflammation
Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells
Xiaoqing Mi, Qijun Li, Xiaoming Wen, Junxia Xie, Youcui Wang, Ning Song · 2021 · Neurochemical Research
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
Frank Y. Shan, Kar‐Ming Fung, Tarek Zieneldien, Janice Kim, Chuanhai Cao, Jason Haitao Huang · 2021 · Life
Toll‐like receptor 10 controls TLR2‐induced cytokine production in monocytes from patients with Parkinson's disease
Hermínio Maurício da Rocha Sobrinho, Rodrigo Saar Gomes, Delson José da Silva, Valéria Bernadete Leite Quixabeira, Leo A. B. Joosten, Cristina Ribeiro de Barros Cardoso, Fátima Ribeiro‐Dias · 2021 · Journal of Neuroscience Research
RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia
Jaegwon Chung, Janna E. Jernigan, Kelly B. Menees, Jae‐Kyung Lee · 2024 · Frontiers in Cellular Neuroscience
Transcellular transmission and molecular heterogeneity of aggregation-prone proteins in neurodegenerative diseases
Eunmin Lee, Hyeonwoo Park, Sangjune Kim · 2024 · Molecules and Cells
⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis
Giselle T. Sagredo, Onur Tanglay, Shrey Shahdadpuri, YuHong Fu, Glenda Margaret Halliday · 2024 · Experimental Neurology
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Sampson, Timothy R., Wallen, Zachary D, Won, Woong-Jai, Standaert, David G., Payami, Haydeh, Harms, Ashley S. · 2025 · Scientific Reports
Brain-derived extracellular vesicles: A promising avenue for Parkinson’s disease pathogenesis, diagnosis, and treatment
Shurui Zhang, Jingwen Li, Xinyu Hu, Hanshu Liu, Qinwei Yu, Guiying Kuang, Long Liu, Danfang Yu, Zhicheng Lin, Nian Xiong · 2025 · Neural Regeneration Research
Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists
Srinivasa Reddy Natala, Agata Habas, Emily M. Stocking, Andrew J. W. Orry, Diana L. Price, Martin B. Gill, Douglas W. Bonhaus, Ruben A Abagyan, Wolfgang Wrasidlo · 2021 · Bioorganic & Medicinal Chemistry Letters
Gut-oriented disease modifying therapy for Parkinson's disease
Chin‐Hsien Lin, Hsin‐Chih Lai, Ming‐Shiang Wu · 2022 · Journal of the Formosan Medical Association
Couldα-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?
Maria Antònia Busquets, Alba Espargaró, Joan Estelrich, Raimon Sabaté · 2015 · BioMed Research International
X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B
Christine A. Vaine, David S. Shin, Christina H. Liu, William T. J. Hendriks, Jyotsna Dhakal, Kyle Shin, Nutan Sharma, D. Cristopher Bragg · 2016 · Neurobiology of Disease
NRF2 at the crossroads of Parkinson’s disease and aging: Mechanistic insights and translational perspectives
Ángel J. García‐Yagüe, Noemí Esteras, Albena T. Dinkova‐Kostova, Rojo AI, Paul G. Shiels, András Dinnyés, Tamas V, Harry van Goor, Isabel Lastres‐Becker · 2026 · Free Radical Biology and Medicine
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
Chiara Sanluca, P. Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti, Giorgio Vivacqua · 2024 · Metabolites
Imaging flow cytometry reveals LPS-induced changes to intracellular intensity and distribution of α-synuclein in a TLR4-dependent manner in STC-1 cells
Anastazja M. Gorecki, Chidozie C. Anyaegbu, Melinda Fitzgerald, Kathryn A. Fuller, Ryan S. Anderton · 2024 · Methods
Manganese Exposure Enhances the Release of Misfolded α-Synuclein via Exosomes by Impairing Endosomal Trafficking and Protein Degradation Mechanisms
Dharmin Rokad, Dilshan S. Harischandra, Manikandan Samidurai, Yuan-Teng Chang, Jie Denny Luo, Vivek Lawana, Souvarish Sarkar, Bharathi N. Palanisamy, Sireesha Manne, Dong-Suk Kim et al. · 2024 · International Journal of Molecular Sciences